Question 1

What insurance policy changes affect CPT 88239?

Accepted Answer

There are 3 tracked policy changes affecting CPT 88239, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Question 2

Which payers have updated policy for CPT 88239?

Accepted Answer

Payers that have issued tracked updates for CPT 88239 include: Aetna.

Question 3

How do I get notified when CPT 88239 policy changes?

Accepted Answer

Create a free account at PolicyChanges.app and save a search filtered to CPT 88239. You will receive a daily digest email whenever a new policy change references this code.

Question 4

Why do payers change policies for CPT 88239?

Accepted Answer

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

88239 Insurance Policy Changes

Tumor Chemosensitivity Assays (CPB 0245, reviewed 2026-04-13)

Tumor Chemoresistance Assays (CPB 0758, reviewed 2025-12-02)

Adoptive Immunotherapy and Cellular Therapy (CPB 0641, reviewed 2025-10-01)